These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 8571669

  • 1. [Immune modulation by vitamin D analogs in the prevention of autoimmune diseases].
    Bouillon R, Verstuyf A, Branisteanu D, Waer M, Mathieu C.
    Verh K Acad Geneeskd Belg; 1995; 57(5):371-85; discussion 385-7. PubMed ID: 8571669
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW, Sergeev IN, Bishop JE, Okamura WH.
    Cancer Res; 1993 Sep 01; 53(17):3935-42. PubMed ID: 8395333
    [Abstract] [Full Text] [Related]

  • 4. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
    Boehm MF, Fitzgerald P, Zou A, Elgort MG, Bischoff ED, Mere L, Mais DE, Bissonnette RP, Heyman RA, Nadzan AM, Reichman M, Allegretto EA.
    Chem Biol; 1999 May 01; 6(5):265-75. PubMed ID: 10322128
    [Abstract] [Full Text] [Related]

  • 5. Vitamin D physiology.
    Lips P.
    Prog Biophys Mol Biol; 2006 Sep 01; 92(1):4-8. PubMed ID: 16563471
    [Abstract] [Full Text] [Related]

  • 6. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK.
    J Endocrinol; 1997 Sep 01; 154 Suppl():S57-73. PubMed ID: 9379138
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
    Brickman AS, Coburn JW, Friedman GR, Okamura WH, Massry SG, Norman AW.
    J Clin Invest; 1976 Jun 01; 57(6):1540-7. PubMed ID: 932193
    [Abstract] [Full Text] [Related]

  • 9. Vitamin D analogs: therapeutic applications and mechanisms for selectivity.
    Brown AJ, Slatopolsky E.
    Mol Aspects Med; 2008 Dec 01; 29(6):433-52. PubMed ID: 18554710
    [Abstract] [Full Text] [Related]

  • 10. The biological activity of nonsteroidal vitamin D hormone analogs lacking both the C- and D-rings.
    Verstuyf A, Verlinden L, Van Baelen H, Sabbe K, D'Hallewyn C, De Clercq P, Vandewalle M, Bouillon R.
    J Bone Miner Res; 1998 Apr 01; 13(4):549-58. PubMed ID: 9556055
    [Abstract] [Full Text] [Related]

  • 11. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.
    Barreto AM, Schwartz GG, Woodruff R, Cramer SD.
    Cancer Epidemiol Biomarkers Prev; 2000 Mar 01; 9(3):265-70. PubMed ID: 10750664
    [Abstract] [Full Text] [Related]

  • 12. The immunological functions of the vitamin D endocrine system.
    Hayes CE, Nashold FE, Spach KM, Pedersen LB.
    Cell Mol Biol (Noisy-le-grand); 2003 Mar 01; 49(2):277-300. PubMed ID: 12887108
    [Abstract] [Full Text] [Related]

  • 13. 1 alpha,25-(OH)2-vitamin D3 analogs with minimal in vivo calcemic activity can stimulate significant transepithelial calcium transport and mRNA expression in vitro.
    Fleet JC, Bradley J, Reddy GS, Ray R, Wood RJ.
    Arch Biochem Biophys; 1996 May 15; 329(2):228-34. PubMed ID: 8638956
    [Abstract] [Full Text] [Related]

  • 14. Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly.
    Reddy GS, Robinson M, Wang G, Palmore GT, Gennaro L, Vouros P, De Clercq P, Vandewalle M, Young W, Ling S, Verstuyf A, Bouillon R.
    Arch Biochem Biophys; 2007 Apr 15; 460(2):254-61. PubMed ID: 17196157
    [Abstract] [Full Text] [Related]

  • 15. Vitamins as hormones.
    Reichrath J, Lehmann B, Carlberg C, Varani J, Zouboulis CC.
    Horm Metab Res; 2007 Feb 15; 39(2):71-84. PubMed ID: 17326003
    [Abstract] [Full Text] [Related]

  • 16. [Vitamin D].
    Miyaura C, Suda T.
    Nihon Rinsho; 1993 Apr 15; 51(4):893-900. PubMed ID: 8483269
    [Abstract] [Full Text] [Related]

  • 17. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
    Eelen G, Verlinden L, Rochel N, Claessens F, De Clercq P, Vandewalle M, Tocchini-Valentini G, Moras D, Bouillon R, Verstuyf A.
    Mol Pharmacol; 2005 May 15; 67(5):1566-73. PubMed ID: 15728261
    [Abstract] [Full Text] [Related]

  • 18. [1,25-dihydroxyvitamin D3: the endocrine system meets the immune system].
    Mathieu C, Decallonne B, van Etten E.
    Verh K Acad Geneeskd Belg; 2002 May 15; 64(1):71-80; discussion 80-2. PubMed ID: 11995203
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships.
    Bischof MG, Redlich K, Schiller C, Chirayath MV, Uskokovic M, Peterlik M, Cross HS.
    J Pharmacol Exp Ther; 1995 Dec 15; 275(3):1254-60. PubMed ID: 8531089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.